SMS Lifesciences India Ltd receives EIR with VAI status from USFDA for API facility at Kazipally

SMS Lifesciences India Limited has received Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. Food and Drug Administration for our API manufacturing facility (Unit 1) located at Kazipally, Telangana, on July 15, 2025 at 09.37 pm.

The receipt of EIR reaffirms the Company's commitment to maintaining global quality standards and enables access to the regulated US market and other highly regulated global markets.

Shares of SMS Lifesciences India Limited was last trading in BSE at Rs. 1143.80 as compared to the previous close of Rs. 1133.80. The total number of shares traded during the day was 992 in over 74 trades.

The stock hit an intraday high of Rs. 1172.75 and intraday low of 1120.05. The net turnover during the day was Rs. 1134755.00.

Source : Equity Bulls

Keywords

SMSLifesciencesIndia INE320X01016 Pharmaceuticals UFDA EIR VAIStatus APIManufacturingFacility Unit1 Kazipally Telangana